Economic Evaluation of Heart Failure Management in Colombian Clinics (EconoHeart)

This study has been completed.
Sponsor:
Information provided by:
AstraZeneca
ClinicalTrials.gov Identifier:
NCT01084564
First received: March 9, 2010
Last updated: NA
Last verified: March 2010
History: No changes posted
  Purpose

Cost effectiveness analysis of local management of patients diagnosed with heart failure disease compared with an ideal guideline-based management.


Condition
Heart Failure
Asthma

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Economic Evaluation of Heart Failure Management in Colombian Clinics

Resource links provided by NLM:


Further study details as provided by AstraZeneca:

Primary Outcome Measures:
  • To determine cost-effectiveness of Heart Failure management in 3 Heart-specialized clinics in Bogotá Colombia [ Time Frame: 12 months ] [ Designated as safety issue: No ]
  • Incremental cost-effectiveness ratio from using Symbicort as symbicort as Maintenance and Reliever Therapy (SMART) when compared with its competitive alternatives [ Designated as safety issue: No ]

Enrollment: 300
Study Start Date: January 2008
Study Completion Date: June 2008
Primary Completion Date: June 2008 (Final data collection date for primary outcome measure)
Groups/Cohorts
1
moderate to severe uncontrolled asthma

  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Moderate to severe uncontrolled asthma.

Criteria

Inclusion Criteria:

  • Asthma moderate to severe.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01084564

Sponsors and Collaborators
AstraZeneca
Investigators
Study Director: Rodolfo Dennis, M.D. Pontificia Universidad Javeriana
Principal Investigator: MARÍA XIMENA ROJAS, M.D. Pontificia Universidad Javeriana
  More Information

No publications provided

Responsible Party: MC MD, AstraZeneca
ClinicalTrials.gov Identifier: NCT01084564     History of Changes
Other Study ID Numbers: NIS-CCO-ATA-2007/1
Study First Received: March 9, 2010
Last Updated: March 9, 2010
Health Authority: Colombia: Institutional Review Board

Keywords provided by AstraZeneca:
Cost-effectiveness analysis
Colombia

Additional relevant MeSH terms:
Heart Failure
Heart Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on September 16, 2014